Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomized Controlled Clinical Trial of Kushen Injection Reducing Radiotherapy Related Adverse Reactions in Lung Cancer

NCT02346318 is registered in ClinicalTrials.gov with Beijing Zheng Ju Medical Technology Co., Ltd. as lead sponsor.

NCT NCT02346318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02346318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomized Controlled Clinical Trial of Kushen Injection Reducing Radiotherapy Related Adverse Reactions in Lung Cancer
Lead sponsor
Beijing Zheng Ju Medical Technology Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2014
Completion date
October 31, 2017
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer